Use of short-acting insulin aspart in managing older people with diabetes

Eltayeb Marouf, Alan J SinclairInstitute of Diabetes for Older People – IDOP, Bedfordshire and Hertfordshire Postgraduate Medical School, University of Bedfordshire, UKAbstract: Type 2 diabetes mellitus affects 5.9% of the world adult population, with older people and some ethnic groups di...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Eltayeb Marouf, Alan J Sinclair
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	insulin aspart elderly older diabetes Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/562fcecd86784ad9abf7f272e0332533
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:562fcecd86784ad9abf7f272e0332533
record_format	dspace
spelling	oai:doaj.org-article:562fcecd86784ad9abf7f272e03325332021-12-02T02:27:52ZUse of short-acting insulin aspart in managing older people with diabetes1178-1998https://doaj.org/article/562fcecd86784ad9abf7f272e03325332009-04-01T00:00:00Zhttps://www.dovepress.com/use-of-short-acting-insulin-aspart-in-managing-older-people-with-diabe-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Eltayeb Marouf, Alan J SinclairInstitute of Diabetes for Older People – IDOP, Bedfordshire and Hertfordshire Postgraduate Medical School, University of Bedfordshire, UKAbstract: Type 2 diabetes mellitus affects 5.9% of the world adult population, with older people and some ethnic groups disproportionately affected. Treatment of older people with diabetes differs in many ways from that in younger adults since the majority have type 2 disease and are at particular risk of macrovascular rather than disabling microvascular disease. Insulin therapy, the most effective of diabetes medications, can reduce any level of elevated HBA1c if used in adequate doses. However, some clinicians are often reluctant to initiate insulin therapy in older people with diabetes mainly out of their concerns about adverse reactions to insulin, particularly hypoglycemia. There is evidence suggesting that insulin aspart appears to act similarly to regular human insulin in older people with type 2 diabetes mellitus. Insulin aspart can be used in the treatment of older people with diabetes, but this should be individualized. There is evidence that it improves postprandial glucose control, improves long-term metabolic control, reduces risk of major nocturnal hypoglycemia and increases patient satisfaction compared with soluble insulin.Keywords: older people, diabetes, insulin aspart, hypoglycemiaEltayeb MaroufAlan J SinclairDove Medical Pressarticleinsulin aspartelderlyolderdiabetesGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 4, Pp 187-190 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	insulin aspart elderly older diabetes Geriatrics RC952-954.6
spellingShingle	insulin aspart elderly older diabetes Geriatrics RC952-954.6 Eltayeb Marouf Alan J Sinclair Use of short-acting insulin aspart in managing older people with diabetes
description	Eltayeb Marouf, Alan J SinclairInstitute of Diabetes for Older People – IDOP, Bedfordshire and Hertfordshire Postgraduate Medical School, University of Bedfordshire, UKAbstract: Type 2 diabetes mellitus affects 5.9% of the world adult population, with older people and some ethnic groups disproportionately affected. Treatment of older people with diabetes differs in many ways from that in younger adults since the majority have type 2 disease and are at particular risk of macrovascular rather than disabling microvascular disease. Insulin therapy, the most effective of diabetes medications, can reduce any level of elevated HBA1c if used in adequate doses. However, some clinicians are often reluctant to initiate insulin therapy in older people with diabetes mainly out of their concerns about adverse reactions to insulin, particularly hypoglycemia. There is evidence suggesting that insulin aspart appears to act similarly to regular human insulin in older people with type 2 diabetes mellitus. Insulin aspart can be used in the treatment of older people with diabetes, but this should be individualized. There is evidence that it improves postprandial glucose control, improves long-term metabolic control, reduces risk of major nocturnal hypoglycemia and increases patient satisfaction compared with soluble insulin.Keywords: older people, diabetes, insulin aspart, hypoglycemia
format	article
author	Eltayeb Marouf Alan J Sinclair
author_facet	Eltayeb Marouf Alan J Sinclair
author_sort	Eltayeb Marouf
title	Use of short-acting insulin aspart in managing older people with diabetes
title_short	Use of short-acting insulin aspart in managing older people with diabetes
title_full	Use of short-acting insulin aspart in managing older people with diabetes
title_fullStr	Use of short-acting insulin aspart in managing older people with diabetes
title_full_unstemmed	Use of short-acting insulin aspart in managing older people with diabetes
title_sort	use of short-acting insulin aspart in managing older people with diabetes
publisher	Dove Medical Press
publishDate	2009
url	https://doaj.org/article/562fcecd86784ad9abf7f272e0332533
work_keys_str_mv	AT eltayebmarouf useofshortactinginsulinaspartinmanagingolderpeoplewithdiabetes AT alanjsinclair useofshortactinginsulinaspartinmanagingolderpeoplewithdiabetes
_version_	1718402467434070016

Use of short-acting insulin aspart in managing older people with diabetes

Ejemplares similares